Improved survival in thrombotic thrombocytopenic purpura–hemolytic uremic syndrome: Clinical experience in 108 patients

New England Journal of Medicine

Volumn 325, Issue 6, 1991, Pages 398-403

  Bell, William R ^a   Ness, Paul M ^a   Kickler, Thomas S ^a   Braine, Hayden G ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; DIPYRIDAMOLE; PREDNISOLONE; PREDNISONE;

ADOLESCENT; ADULT; AGED; ARTICLE; COMPLICATION; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEMOLYTIC ANEMIA; HEMOLYTIC UREMIC SYNDROME; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEUROLOGIC DISEASE; ORAL DRUG ADMINISTRATION; PLASMAPHERESIS; PRIORITY JOURNAL; THROMBOTIC THROMBOCYTOPENIC PURPURA;

EID: 0025999820     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM199108083250605     Document Type: Article

References (54)

1. Moschcowitz E. Hyaline thrombosis of the terminal arterioles and capillaries: a hitherto undescribed disease. Proc N Y Pathol Soc 1924; 24:21-24
2. Gasser C., Gautier E., Steck A., Siebenmann R.E., Oechslin R. Hämolytischurämische Syndrome: bilaterale Nierenrindennnekrosen bei akuten erworbenen hämolytischen Anämien. Schweiz Med Wochenschr 1955; 85:905-9
3. Byrnes J.J., Moake J.L. Thrombotic thrombocytopenic purpura and the haemolytic-uraemic syndrome: evolving concepts of pathogenesis and therapy. Clin Haematol 1986; 15:413-42
4. Remuzzi G. HUS and TTP: variable expression of a single entity. Kidney Int 1987; 32:292-308
5. Rubenstein M.A., Kagan B.M., MacGillviray M.H., Merliss R., Sacks H. Unusual remission in a case of thrombotic thrombocytopenic purpura syndrome following fresh blood exchange transfusions. Ann Intern Med 1959; 51:1409-19
6. Bukowski R.M., Hewlett J.S., Harris J.W., et al. Exchange transfusion in the treatment of thrombotic thrombocytopenic purpura. Semin Hematol 1976; 13:219-32
7. Armitage P. Statistical methods in medical research. Oxford, England: Blackwell Scientific, 1983: 99-147
8. Murphy E.A. Biostatistics in medicine. Baltimore: Johns Hopkins University Press, 1982
9. Kaplan E.L., Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53:457-81
10. Lambert S.R., High K.A., Cotlier E., Benz E.J. Jr. Serous retinal detachments in thrombotic thrombocytopenic purpura. Arch Ophthalmol 1985; 103: 1172-4
11. Singer K. Thrombotic thrombocytopenic purpura. Adv Intern Med 1954; 6:195-234
12. Amorosi E.L., Ultmann J.E. Thrombotic thrombocytopenic purpura: report of 16 cases and review of literature. Medicine (Baltimore) 1966; 45:139-59
13. Byrnes J.J., Khurana M. Treatment of thrombotic thrombocytopenic purpura with plasma. N Engl J Med 1977; 297:1386-9
14. Ansell J., Beaser R.S., Pechet L. Thrombotic thrombocytopenic purpura fails to respond to fresh frozen plasma infusion. Ann Intern Med 1978; 89:647-8
15. Aster R.H. Plasma therapy for thrombotic thrombocytopenic purpura: sometimes it works, but why? N Engl J Med 1985; 312:985-7
16. Lian E.C.Y. Pathogenesis of thrombotic thrombocytopenic purpura. Semin Hematol 1987; 24:82-100
17. Ridolfi R.L., Bell W.R. Thrombotic thrombocytopenic purpura: report of 25 cases and review of the literature. Medicine (Baltimore) 1981; 60:413-28
18. Reynolds P.M., Jackson J.M., Brine J.A.S., Vivian A.B. Thrombotic thrombocytopenic purpura — remission following splenectomy. Am J Med 1976; 61:439-47
19. Cuttner J. Thrombotic thrombocytopenic purpura: a ten-year experience. Blood 1980; 56:302-6
20. Joneau M., Cordonnier C., Vernant J.P., Touzet C., Sobel A. How many plasma exchanges to cure thrombotic thrombocytopenic purpura? Scand J Haematol 1985; 34:157-9
21. Lian E.C.Y., Savaraj N. Effects of platelet inhibitors on the platelet aggregation induced by plasma from patients with thrombotic thrombocytopenic purpura. Blood 1981; 58:354-9
22. Myers T.J. Treatment of thrombotic thrombocytopenic purpura with combined exchange plasmapheresis and anti-platelet agents. Semin Thromb Hemost 1981; 7:37-42
23. Rosove M.H., Ho W.G., Goldfinger D. Ineffectiveness of aspirin and dipyridamole in the treatment of thrombotic thrombocytopenic purpura. Ann Intern Med 1982; 96:27-33
24. Breckenridge R.L. Jr., Solberg L.A., Pineda A.A., Petitt R.M., Dharkar D. Treatment of thrombotic thrombocytopenic purpura with plasma exchange, antiplatelet agents, corticosteroid, and plasma infusion. J Clin Apheresis 1982; 1:6-13
25. Caggiano V., Fernando L.P., Schneider J.M., Haesslein H.C., Watson-Williams E.J. Thrombotic thrombocytopenic purpura: report of fourteen cases — occurrence during pregnancy and response to plasma exchange. J Clin Apheresis 1983; 1:71-85
26. Bukowski R.M., Hewlett J.S., Reimer R.R., Groppe C.W., Weick J.R., Livingston R.B. Therapy of thrombotic thrombocytopenic purpura: an overview. Semin Thromb Hemost 1981; 7:1-8
27. Harkness D.R., Byrnes J.J., Lian E.C.Y., Williams W.D., Hensky G.T. Hazard of platelet transfusion in thrombotic thrombocytopenic purpura. JAMA 1981; 246:1931-3
28. Rothberg H., Pachter I., Kosmin M., Stevens D.B. Thrombotic thrombocytopenic purpura: recovery after plasmapheresis, corticosteroids, splenectomy, and antiplatelet agents. Am J Hematol 1982; 12:281-7
29. Gordon L.I., Kwaan H.C., Rossi E.C. Deleterious effects of platelet transfusions and recovery thrombocytosis in patients with thrombotic microangiopathy. Semin Hematol 1987; 24:194-201
30. Moake J.L., Rudy C.K., Troll J.H., et al. Unusually large plasma factor VIII: von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura. N Engl J Med 1982; 307:1432-5
31. Feldman J.D., Mardiney M.R., Unanue E.R., Cutting H. The vascular pathology of thrombotic thrombocytopenic purpura. Lab Invest 1966; 15:927-46
32. Katz J.A., Moake J.L., McPherson P.D., et al. Relationship between human development and disappearance of unusually large von Willebrand factor multimers from plasma. Blood 1989; 73:1851-8
33. Moore J.C., Murphy W.G., Kelton J.G. Calpain proteolysis of von Willebrand factor enhances its binding to platelet membrane glycoprotein llb/111a: an explanation for platelet aggregation in thrombotic thrombocytopenic purpura. Br J Haematol 1990; 74:457-64
34. Rose M., Eldor A. High incidence of relapses in thrombotic thrombocytopenic purpura. Am J Med 1987; 83:437-44
35. Jokela J., Flynn T., Henry K. Thrombotic thrombocytopenic purpura in a human immunodeficiency virus (HIV)-seropositive homosexual man. Am J Hematol 1987; 25:341-3
36. Meisenberg B.R., Robinson W.L., Mosley C.A., Duke M.S., Rabetoy G.M., Kosty M.P. Thrombotic thrombocytopenic purpura in human immunodeficiency (HlV)-seropositive males. Am J Hematol 1988; 27:212-5
37. Nair J.M.G., Bellevue R., Bertoni M., Dosik H. Thrombotic thrombocytopenic purpura in patients with acquired immunodeficiency syndrome (AIDS)-related complex. Ann Intern Med 1988; 109:209-12
38. Leaf A.N., Laubenstein L.J., Raphael B., Hochster H., Baez L., Karpatkin S. Thrombotic thrombocytopenic purpura associated with human immunodeficiency virus type 1 (HIV-1) infection. Ann Intern Med 1988; 109:194-7
39. Botti AC, Hyde P., DiPillo F. Thrombotic thrombocytopenic purpura in a patient who subsequently developed the acquired immunodeficiency syndrome (AIDS). Ann Intern Med 1988; 109:242-3
40. Segal G.H., Tubbs R.R., Ratliff N.B., Miller M.L., Longworth D.L. Thrombotic thrombocytopenic purpura in a patient with AIDS. Cleve Clin J Med 1990; 57:360-6
41. Harrington W.J., Lian E., Temple J.D. Jr., Rabin M., Miller G., Harrington T. Retroviral associated thrombotic thrombocytopenic purpura. Blood 1990; 76:Suppl 1:487a. abstract
42. GilcherRO. Refractory TTP responding to IV gammaglobulin. Blood 1984; 64:Suppl 1:237a. abstract
43. Krishnamurthy M., Bellevue R., Lian E., et al. Intravenous immunoglobulin in thrombotic thrombocytopenic purpura — a new mode of treatment. Blood 1985; 66:Suppl 1:291a. abstract
44. Messmore H.L., Yeshwant C., Remlinger K., Seghatchian M.J. Intravenous gamma globulin in refractory thrombotic thrombocytopenic purpura (TTP). Thromb Haemost 1985; 54:127. abstract
45. Viero P., Cortelazzo S., Buelli M., et al. Thrombotic thrombocytopenic purpura and high-dose immunoglobulin treatment. Ann Intern Med 1986; 104:282
46. Wong P., Itoh K., Yoshida S. Treatment of thrombotic thrombocytopenic purpura with intravenous gamma globulin. N Engl J Med 1986; 314:385-6
47. Kelton J.G., Moore J.C., Murphy W.G. Studies investigating platelet aggregation and release initiated by sera from patients with thrombotic thrombocytopenic purpura. Blood 1987; 69:924-8
48. Finn N.G., Wang J.C., Hong K.J. High-dose intravenous gamma-immunoglobulin infusion in the treatment of thrombotic thrombocytopenic purpura. Arch Intern Med 1987; 147:2165-7
49. Chin D., Chyczij H., Etches W., Gordon P., King E. Treatment of thrombotic thrombocytopenic purpura with intravenous gammaglobulin. Transfusion 1987; 27:115-6
50. Siddiqui F.A., Lian E.Y.C. Platelet-agglutinating protein P37 from a thrombotic thrombocytopenic purpura plasma forms a complex with human immunoglobulin G. Blood 1988; 71:299-304
51. Schmidt J.L. Thrombotic thrombocytopenic purpura: successful treatment unlocks etiologic secrets. Mayo Clin Proc 1989; 64:956-61
52. Heyman M.R., Sweet T. Thrombotic thrombocytopenic purpura treated with high-dose intravenous gamma globulin. South Med J 1990; 83:1471-4
53. Raniele D.P., Opsahl J.A., Jensen N.J., Crosson J.C., Kiellstrand C.M. Treatment of thrombotic thrombocytopenic purpura (TTP) with intravenous immunoglobulin G (lgG): 88% response rate. In: International Society for Blood Transfusion and American Association of Blood Banks book of abstracts. Vol. 1. Arlington. Va.: American Association of Blood Banks. 1990: 90. abstract
54. Gutterman L. Treatment of thrombotic thrombocytopenic purpura (ITP) with exchange plasmapheresis (EP), vincristine (VCR), and methylprednisolone (MP): a standardized initial treatment in 11 patients. Blood 1990; 76: Suppl 1:509a. abstract